Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
about
Pharmacotherapies for obesity: past, current, and future therapiesTackling obesity: new therapeutic agents for assisted weight loss.Combinations of drugs in the Treatment of Obesity.Serotonin and norepinephrine reuptake inhibition and eating behavior.Evaluation of efficacy and safety of orlistat in obese patients.Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study.In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice.Comparative efficiency and safety of pharmacological approaches to the management of obesity.Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy.The use of sibutramine in the management of obesity and related disorders: an update.Current pharmacotherapeutic concepts for the treatment of obesity in adults.The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.Orlistat: current status in clinical therapeutics.Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?Fixed-dose combination of phentermine-topiramate for the treatment of obesity.Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo.Centrally Acting Agents for Obesity: Past, Present, and Future
P2860
Q21296814-1B42BBEC-6137-4DC6-A81B-12023F07CDE8Q30401145-CFB5343E-81FC-464E-8390-DC13E69F08B9Q33664063-2D4043FB-36C7-4B5B-BD28-241E2460CFC7Q34587982-8623C862-1D17-4D9B-ADC3-BF98B5BC8BCDQ35073399-248936C0-8475-4C72-80C0-E728C0143AD9Q35686326-158EB025-B234-4D56-8161-F21085065D81Q36044388-E2E8C840-C851-4C08-8692-BDF3D3891A7BQ36783891-8062BC70-067A-42A2-9BCD-EA81A57674D8Q37079243-BE0C527D-C676-40DE-A7FA-B496386838CEQ37202159-59FF9491-E9BD-4E79-A300-15E869ED6939Q37368688-12DAA5B6-C3C9-46E8-AFF1-8B2E6AF264F4Q37494318-CD1D7671-36A0-4C43-9ED2-121425176B4FQ37649644-83AB7145-6AF0-4504-952E-E9017E6B07F6Q37831334-1B891468-6812-445E-AC23-DF132085F7B0Q38105146-987A53F4-9275-4160-8369-839F150E7385Q47413484-A2A6112D-3184-44B4-AAB5-FAA3F26814A5Q57177981-B97FEC12-C53B-4895-B262-C5A60898A847
P2860
Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Comparison of efficacy of sibu ...... ir combination in obese women.
@en
Comparison of efficacy of sibu ...... ir combination in obese women.
@nl
type
label
Comparison of efficacy of sibu ...... ir combination in obese women.
@en
Comparison of efficacy of sibu ...... ir combination in obese women.
@nl
prefLabel
Comparison of efficacy of sibu ...... ir combination in obese women.
@en
Comparison of efficacy of sibu ...... ir combination in obese women.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of efficacy of sibutramine or orlistat versus their combination in obese women
@en
P2093
Hasan Altunbas
Mehtap Cakir
Ramazan Sari
Umit Karayalcin
P2860
P304
P356
10.1081/ERC-200027356
P577
2004-05-01T00:00:00Z